findmyKOL
Clinical trialNCT01444092CompletedPhase 3Interventional

Safety Study of Entocort for Children With Crohn's Disease

SponsorPadagis LLCEnrollment123Crohn's Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Safety Study using Entocort EC for children with mild to moderate Crohn's Disease

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Stanley Cohen, MD

    Children's Center for Digestive Healthcare, LLC, Atlanta, Georgia, USA and Emory University School of Medicine, Atlanta, Georgia, USA

    Principal Investigator
  • Stefan Eklund, MD

    AstraZeneca Pharmaceuticals, Mölndal, Sweden

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Research Site

    Halifax, Nova Scotia, Canada

  • Research Site

    London, Ontario, Canada

  • Research Site

    Toronto, Ontario, Canada

Germany
  • Research Site

    München, Germany

Italy
  • Research Site

    Florence, Italy

  • Research Site

    Messina, Italy

  • Research Site

    Naples, Italy

  • Research Site

    Roma, Italy

Poland
  • Research Site

    Krakow, Poland

  • Research Site

    Lodz, Poland

  • Research Site

    Rzeszów, Poland

  • Research Site

    Warsaw, Poland

  • Research Site

    Wroclaw, Poland

United States
  • Research Site

    Aurora, Colorado, United States

  • Research Site

    Atlanta, Georgia, United States

  • Research Site

    Chicago, Illinois, United States

  • Research Site

    Oak Lawn, Illinois, United States

  • Research Site

    Boston, Massachusetts, United States

  • Research Site

    Saint Paul, Minnesota, United States

  • Research Site

    Mays Landing, New Jersey, United States

  • Research Site

    Morristown, New Jersey, United States

  • Research Site

    Buffalo, New York, United States

  • Research Site

    Greenville, North Carolina, United States

  • Research Site

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Entocort
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2011
Primary completion
30 Sept 2014
Completion
30 Sept 2014
Last update posted
6 Jan 2022
Registered enrollment
123
Registry id
NCT01444092

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.